TEVAHealthcareLarge-Cap
TEVA PHARMACEUTICAL INDUSTRIES LTD Insider Trading Activity
Every SEC Form 4 insider transaction reported for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are TEVA insiders buying or selling?
TEVA PHARMACEUTICAL INDUSTRIES LTD insiders reported 5 open-market buys ($16.5M) and 210 sells ($145.4M) across 215 Form 4 filings — a net selling position of $128.9M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jun 22, 2026)
Total Form 4 filings
215
SEC EDGAR
Insider filers
28
Insider buys (5)
$16.5M
Insider sells (210)
$145.4M
Insider sentiment
Net sellingNet insider flow of $128.9M in net selling.
Recent TEVA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | Matthew Shields | EVP, Global Operations | Sale | 10.0K | $32.19 | $321.5K |
| Jun 16, 2026 | Eliyahu Sharon Kalif | EVP, Chief Financial Officer | Sale | 106.6K | $34.10 | $3.6M |
| Jun 8, 2026 | Richard D Francis | President and CEO | Sale | 6.2K | $34.35 | $211.4K |
| Jun 4, 2026 | Matthew Shields | EVP, Global Operations | Sale | 16.2K | $32.87 | $532.3K |
| May 18, 2026 | Evan Lippman | EVP, Business Development | Sale | 41.7K | $35.58 | $1.5M |
| May 18, 2026 | Eliyahu Sharon Kalif | EVP, Chief Financial Officer | Sale | 153.3K | $35.61 | $5.5M |
| May 7, 2026 | Amir Weiss | Chief Accounting Officer | Sale | 10.7K | $36.00 | $384.4K |
| May 7, 2026 | Richard Daniell | EVP, Europe Commercial | Sale | 30.0K | $35.40 | $1.1M |
| May 4, 2026 | Mark Sabag | See "Remarks" | Sale | 144.2K | $34.99 | $5.0M |
| May 4, 2026 | Christine Fox | EVP, U.S. Commercial | Sale | 21.3K | $35.31 | $750.6K |
| Mar 19, 2026 | Mark Sabag | See "Remarks" | Sale | 62.1K | $30.14 | $1.9M |
| Mar 9, 2026 | Richard D Francis | President and CEO | Sale | 20.0K | $31.67 | $634.2K |
| Mar 9, 2026 | Christine Fox | EVP, U.S. Commercial | Sale | 7.9K | $31.67 | $250.9K |
| Mar 9, 2026 | Eric A Hughes | See "Remarks" | Sale | 9.5K | $31.67 | $301.9K |
| Mar 9, 2026 | Richard Daniell | EVP, Europe Commercial | Sale | 17.3K | $31.67 | $547.7K |
| Mar 9, 2026 | Placid Jover | See "Remarks" | Sale | 14.2K | $31.67 | $448.1K |
| Mar 9, 2026 | Brian Savage | Interim Chief Legal Officer | Sale | 1.1K | $31.67 | $35.7K |
| Mar 9, 2026 | Matthew Shields | EVP, Global Operations | Sale | 17.3K | $31.67 | $547.7K |
| Mar 6, 2026 | Richard D Francis | President and CEO | Sale | 23.4K | $32.46 | $759.4K |
| Mar 6, 2026 | Richard Daniell | EVP, Europe Commercial | Sale | 91.3K | $32.66 | $3.0M |
| Mar 6, 2026 | Eric A Hughes | See "Remarks" | Sale | 11.3K | $32.46 | $366.1K |
| Mar 6, 2026 | Christine Fox | EVP, U.S. Commercial | Sale | 9.1K | $32.46 | $295.4K |
| Mar 6, 2026 | Brian Savage | Interim Chief Legal Officer | Sale | 2.7K | $32.46 | $86.8K |
| Mar 2, 2026 | Eliyahu Sharon Kalif | EVP, Chief Financial Officer | Sale | 345.8K | $33.64 | $11.6M |
| Feb 18, 2026 | Richard D Francis | President and CEO | Sale | 447.8K | $34.22 | $15.3M |
Showing the 25 most recent of 215 Form 4 filings for TEVA PHARMACEUTICAL INDUSTRIES LTD.
Most active TEVA insiders
- Richard Daniell31 filings
- Hafrun Fridriksdottir21 filings
- David Matthew Stark17 filings
- Eric Drape16 filings
- Sven Dethlefs15 filings
Ask anything about TEVA insider activity
Use Trabud's AI agent to query TEVA PHARMACEUTICAL INDUSTRIES LTD's Form 4 history in plain English — "Show me TEVA CEO purchases this year" or compare it against any other ticker.
Open the AI agentTEVA insider trading FAQ
Are TEVA PHARMACEUTICAL INDUSTRIES LTD insiders buying or selling?
Across 215 SEC Form 4 filings, TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) insiders reported 5 open-market purchases totaling $16.5M and 210 sales totaling $145.4M. That is a net selling position of $128.9M.
How many insiders trade TEVA stock?
28 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for TEVA PHARMACEUTICAL INDUSTRIES LTD. The most recent filing was accepted on Jun 22, 2026.
Where does Trabud get TEVA insider trading data?
All TEVA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.